In a written statement, the provincial government said there are currently 3,420 active cases of people infected with the novel coronavirus in British Columbia. A total of 358 people are hospitalized, including 109 in intensive care.
Overall hospitalizations, which typically lag behind peaks and declines in new cases, are down nearly 7% from last Friday, when 384 people were hospitalized with the disease.
The number of intensive care patients is down about 12% from 124 a week ago.
The provincial death toll from COVID-19 is now 2,293 lives lost out of 214,636 cases confirmed to date.
The regional distribution of new cases is as follows:
- 146 new cases in Interior Health, which has 657 active cases in total.
- 138 new cases at Fraser Health, with a total of 1,244 active cases.
- 78 new cases at Northern Health, which has 498 active cases in total.
- 71 new cases at Island Health, which has 454 active cases in total.
- 64 new cases at Vancouver Coastal Health, which has 511 active cases in total.
- There are no new cases among people residing outside of Canada, a group with a total of 56 active cases.
There are a total of 21 active outbreaks in assisted living, long-term and short-term care facilities.
A new outbreak has been declared at Laurier Manor, an assisted living facility in Prince George. The province has declared the end of an outbreak at Rosemary Heights Seniors Village in Surrey.
Acute care outbreaks include:
- Abbotsford Regional Hospital
- Burnaby Hospital
- Hôpital Ridge Meadows
- Royal Inland Hospital
- Nanaimo Regional General Hospital
As of Friday, 90.8% of those 12 and over in British Columbia had received their first dose of a COVID-19 vaccine and 87% a second dose.
From Nov. 11 to 17, people who were not fully vaccinated accounted for 59.5% of cases and as of Nov. 4, they accounted for 70.4% of hospitalizations, according to the province.
So far, 8.5 million doses of COVID-19 vaccine have been administered, including 4.03 million second doses.
Pfizer-BioNTech vaccine approved for children 5 to 11 years old
On Friday morning, Canada approved the Pfizer-BioNTech COVID-19 vaccine for children aged five to 11.
“After a thorough and independent scientific review of the evidence, the ministry has determined that the benefits of this vaccine for children aged five to 11 outweigh the risks,” Health Canada wrote in a statement Friday morning.
“This is the first COVID-19 vaccine authorized in Canada for use in this age group and marks an important milestone in Canada’s fight against COVID-19. “
Pfizer-BioNTech vaccine is given at doses one-third of those given to adults and children 12 years of age and older. Health Canada has authorized the administration of a two-dose regimen three weeks apart.
The first doses of the vaccine for people aged 5 to 11 will begin arriving in Canada on Sunday, Public Services and Supply Minister Filomena Tassi said on Friday.
Tassi said the government and Pfizer-BioNTech have already agreed on an expedited delivery schedule and that more than 2.9 million doses will be shipped by the end of the week – enough to provide a first dose for every child eligible Canadian.